API australian pharmaceutical industries limited

big question marks ??????????, page-80

  1. 39 Posts.
    I think API is quite cheap now. With the no debt by year end and a P/E ratio of slightly above 13, relatively low for the industry, I can't see it drifting to the 1.4 mark but then again stranger things have happened. If I'm going by logic I see the stock sitting at the higher 1.5's by the end of next week.

    They also have a lot of room for inorganic growth through an acquisition. Will be good to see the strategy when the end of year results come out.
    Last edited by Al25: 01/09/17
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.